ID   CDK18_HUMAN             Reviewed;         472 AA.
AC   Q07002; Q5VXQ2; Q6V3A2; Q6V3A3; Q96F90;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   15-MAR-2017, entry version 173.
DE   RecName: Full=Cyclin-dependent kinase 18;
DE            EC=2.7.11.22;
DE   AltName: Full=Cell division protein kinase 18;
DE   AltName: Full=PCTAIRE-motif protein kinase 3;
DE   AltName: Full=Serine/threonine-protein kinase PCTAIRE-3;
GN   Name=CDK18; Synonyms=PCTAIRE3, PCTK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), AND TISSUE SPECIFICITY.
RC   TISSUE=Hippocampus;
RX   PubMed=15019984; DOI=10.1016/j.gene.2003.12.011;
RA   Herskovits A.Z., Davies P.;
RT   "Cloning and expression analysis of two novel PCTAIRE 3 transcripts
RT   from human brain.";
RL   Gene 328:59-67(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   MET-164.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   MET-164.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 93-472.
RX   PubMed=1639063;
RA   Meyerson M., Enders G.H., Wu C.-L., Su L.-K., Gorka C., Nelson C.,
RA   Harlow E., Tsai L.-H.;
RT   "A family of human cdc2-related protein kinases.";
RL   EMBO J. 11:2909-2917(1992).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72; SER-87 AND SER-115,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-87 AND SER-130,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72; SER-87; SER-96 AND
RP   SER-115, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-46; ARG-65 AND MET-164.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May play a role in signal transduction cascades in
CC       terminally differentiated cells.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- INTERACTION:
CC       A1A4H1:CCDC102B; NbExp=3; IntAct=EBI-746238, EBI-10171570;
CC       O95273:CCNDBP1; NbExp=3; IntAct=EBI-746238, EBI-748961;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-746238, EBI-618309;
CC       Q9BVG8:KIFC3; NbExp=3; IntAct=EBI-746238, EBI-2125614;
CC       Q15323:KRT31; NbExp=3; IntAct=EBI-746238, EBI-948001;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-746238, EBI-10171697;
CC       Q9BRK4:LZTS2; NbExp=3; IntAct=EBI-746238, EBI-741037;
CC       Q8TD10:MIPOL1; NbExp=3; IntAct=EBI-746238, EBI-2548751;
CC       Q5JR59:MTUS2; NbExp=3; IntAct=EBI-746238, EBI-742948;
CC       Q8ND90:PNMA1; NbExp=3; IntAct=EBI-746238, EBI-302345;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-746238, EBI-719493;
CC       Q9BYV2:TRIM54; NbExp=3; IntAct=EBI-746238, EBI-2130429;
CC       Q9BZW7:TSGA10; NbExp=3; IntAct=EBI-746238, EBI-744794;
CC       P63104:YWHAZ; NbExp=2; IntAct=EBI-746238, EBI-347088;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q07002-1; Sequence=Displayed;
CC       Name=2; Synonyms=3a;
CC         IsoId=Q07002-2; Sequence=VSP_035888;
CC       Name=3; Synonyms=3b;
CC         IsoId=Q07002-3; Sequence=VSP_035888, VSP_035889;
CC   -!- TISSUE SPECIFICITY: Isoform 3 expression is limited to several
CC       subcortical nuclei of the basal gangli and the spinal cord.
CC       Isoform 2 is widely expressed. {ECO:0000269|PubMed:15019984}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY353237; AAR13065.1; -; mRNA.
DR   EMBL; AY353238; AAR13066.1; -; mRNA.
DR   EMBL; BT007299; AAP35963.1; -; mRNA.
DR   EMBL; AL357131; CAH72012.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91559.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91560.1; -; Genomic_DNA.
DR   EMBL; BC011526; AAH11526.1; -; mRNA.
DR   EMBL; X66362; CAA47005.1; -; mRNA.
DR   CCDS; CCDS1454.1; -. [Q07002-3]
DR   CCDS; CCDS44300.1; -. [Q07002-2]
DR   PIR; S32831; S32831.
DR   RefSeq; NP_002587.2; NM_002596.3. [Q07002-2]
DR   RefSeq; NP_997667.1; NM_212502.2. [Q07002-2]
DR   RefSeq; NP_997668.1; NM_212503.2. [Q07002-3]
DR   UniGene; Hs.445402; -.
DR   ProteinModelPortal; Q07002; -.
DR   SMR; Q07002; -.
DR   BioGrid; 111156; 59.
DR   IntAct; Q07002; 77.
DR   MINT; MINT-3294654; -.
DR   BindingDB; Q07002; -.
DR   ChEMBL; CHEMBL5316; -.
DR   GuidetoPHARMACOLOGY; 1971; -.
DR   iPTMnet; Q07002; -.
DR   PhosphoSitePlus; Q07002; -.
DR   DMDM; 116242704; -.
DR   EPD; Q07002; -.
DR   MaxQB; Q07002; -.
DR   PeptideAtlas; Q07002; -.
DR   PRIDE; Q07002; -.
DR   DNASU; 5129; -.
DR   Ensembl; ENST00000360066; ENSP00000353176; ENSG00000117266. [Q07002-2]
DR   Ensembl; ENST00000429964; ENSP00000399082; ENSG00000117266. [Q07002-2]
DR   Ensembl; ENST00000506784; ENSP00000423665; ENSG00000117266. [Q07002-3]
DR   GeneID; 5129; -.
DR   KEGG; hsa:5129; -.
DR   UCSC; uc001hcp.4; human. [Q07002-1]
DR   CTD; 5129; -.
DR   DisGeNET; 5129; -.
DR   GeneCards; CDK18; -.
DR   HGNC; HGNC:8751; CDK18.
DR   HPA; HPA045429; -.
DR   MIM; 169190; gene.
DR   neXtProt; NX_Q07002; -.
DR   OpenTargets; ENSG00000117266; -.
DR   PharmGKB; PA33097; -.
DR   GeneTree; ENSGT00790000122986; -.
DR   HOGENOM; HOG000233024; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; Q07002; -.
DR   KO; K15596; -.
DR   OMA; HDLIHTD; -.
DR   OrthoDB; EOG091G0CH0; -.
DR   PhylomeDB; Q07002; -.
DR   TreeFam; TF106508; -.
DR   BRENDA; 2.7.11.22; 2681.
DR   SignaLink; Q07002; -.
DR   ChiTaRS; CDK18; human.
DR   GeneWiki; PCTK3; -.
DR   GenomeRNAi; 5129; -.
DR   PRO; PR:Q07002; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117266; -.
DR   CleanEx; HS_PCTK3; -.
DR   ExpressionAtlas; Q07002; baseline and differential.
DR   Genevisible; Q07002; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    472       Cyclin-dependent kinase 18.
FT                                /FTId=PRO_0000086490.
FT   DOMAIN      142    423       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     148    156       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    263    263       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     171    171       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      12     12       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      72     72       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES      87     87       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      96     96       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     115    115       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES     130    130       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     438    438       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35832}.
FT   MOD_RES     441    441       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35832}.
FT   VAR_SEQ       1      1       M -> MIM (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:15019984}.
FT                                /FTId=VSP_035888.
FT   VAR_SEQ      89     89       E -> EVRASGALPRQVAGCTHKGVHRRAAALQPDF (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:15019984}.
FT                                /FTId=VSP_035889.
FT   VARIANT      46     46       G -> S. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_047802.
FT   VARIANT      65     65       G -> R. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_047803.
FT   VARIANT     164    164       T -> M. {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_047804.
FT   CONFLICT    256    256       H -> T (in Ref. 6; CAA47005).
FT                                {ECO:0000305}.
FT   CONFLICT    321    321       D -> A (in Ref. 6; CAA47005).
FT                                {ECO:0000305}.
FT   CONFLICT    405    405       L -> V (in Ref. 6; CAA47005).
FT                                {ECO:0000305}.
SQ   SEQUENCE   472 AA;  54180 MW;  5CD938D3565BD01A CRC64;
     MNKMKNFKRR FSLSVPRTET IEESLAEFTE QFNQLHNRRN ENLQLGPLGR DPPQECSTFS
     PTDSGEEPGQ LSPGVQFQRR QNQRRFSMED VSKRLSLPMD IRLPQEFLQK LQMESPDLPK
     PLSRMSRRAS LSDIGFGKLE TYVKLDKLGE GTYATVFKGR SKLTENLVAL KEIRLEHEEG
     APCTAIREVS LLKNLKHANI VTLHDLIHTD RSLTLVFEYL DSDLKQYLDH CGNLMSMHNV
     KIFMFQLLRG LAYCHHRKIL HRDLKPQNLL INERGELKLA DFGLARAKSV PTKTYSNEVV
     TLWYRPPDVL LGSTEYSTPI DMWGVGCIHY EMATGRPLFP GSTVKEELHL IFRLLGTPTE
     ETWPGVTAFS EFRTYSFPCY LPQPLINHAP RLDTDGIHLL SSLLLYESKS RMSAEAALSH
     SYFRSLGERV HQLEDTASIF SLKEIQLQKD PGYRGLAFQQ PGRGKNRRQS IF
//
